Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: Correlation with haematological parameters

Marius Horger^*, P. Pereira, C. D. Claussen, L. Kanz, R. Vonthein, B. Denecke, C. Driessen

^*Corresponding author for this work